Summary
In five of eight members of a three generation family the existence of a silent allele of the properdin factor B polymorphism (BF*QO) was indicated by immunofixation of BF electrophoretic variants and by the hemolytic overlay after isoelectric focusing of BF allotypes. This was further supported by the results of HLA-A, B, C, DR, C2, C4A, C4B, GLO-typing. BF protein was decreased in all heterozygous BF deficient family members. The absolute hemolytic activity, however, was obviously compensated for by an increased relative functional activity of the normal S or F alleles on the other chromosome.
Similar content being viewed by others
References
Alper CA, Boenisch T, Watson L (1972) Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 135:68–80
Awdeh ZL, Raum D, Yunis EJ, Alper CA (1983) Extended HLA-complement-glyoxalase allele haplotype: Evidence for Tt-like complex in man. Proc Natl Acad Sci USA 80:259–263
Dewald G, Rittner Ch (1980) Polymorphism of the second component of human complement: Observation of the rare phenotype C2 (C2B) and data on the localization of the C2 locus in the HLA region. Vox Sang 37:47–54
Kömpf J, Bissbort S, Gussmann S, Ritter H (1975) Polymorphism of red cell glyoxalase I (E.C.: 4.41I). A new genetic marker in man. Humangenetik 27:141–143
Lachmann PJ (1984) Inherited complement deficiencies. Philos Trans R Soc Lond [Biol] 306:419–430
Lowry R, Goguen J, Strom TB, Gorovoy MR (1979) Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations. Tissue Antigens 14:325–330
Martin A, Lachmann PJ, Halbwachs L, Hobart MJ (1976) Hemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry 13:317–324
Mauff G, Federmann G, Hauptmann G (1980) A hemolytically inactive gene product of factor B. Immunobiology 158:96–100
Mauff G, Alper CA, Awdeh Z, Batchelor JR, Bertrams J, Bruun-Petersen G, Dawkins RL, Demant P, Edwards J, Grosse-Wilde H, Hauptmann G, Klouda P, Lamm L, Mollenhauer E, Nerl C, Olaisen B, O'Neill G, Rittner Ch, Roos MH, Skanes V, Teisberg P, Wells L (1983) Statement on the nomenclature of human C4 allotypes. Immunbiology 164:184–191
O'Neill GJ, Miniter P, Nerl Ch, Yang SY, Dupont B, Pollack MS (1982). The BF locus and HLA: Rare alleles coding for functionally active and inactive factor-B products. Hum Immunol 5:239–246
Suciu-Foca N, O'Neill G, Rubinstein P (1980) Evidence for the existence of a possible Bf “null” allele. In: Terasaki PI (ed) Histocompatibility Testing 1980. UCLA Tissue Typing Laboratory, Los Angeles, pp 935–936
Terasaki PI, McClelland JD (1964) Microdroplet assay of human serum cytotoxins. Nature 204:998–1000
Tokunaga K, Omoto K, Yukiyama Y, Sakurai M, Saji H, Maruy E (1984) Further study on a BF silent allele. Hum Genet 67:449–451
Weidinger S, Schwarzfischer E, Cleve H (1979) Properdin factor B-polymorphism: An indication for the existence of a Bfo allele. Z Rechtsmed 83:259–264
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertrams, J., Mauff, G. Another family with a silent allele of properdin factor B polymorphism (BF*QO). Hum Genet 70, 321–323 (1985). https://doi.org/10.1007/BF00295369
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00295369